Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Breast 1

Conditions

Neuroma, Acoustic 2

Interventions

Saline Solution 6Dexmedetomidine 5Sodium Chloride 4Temozolomide 3Sevoflurane 3Propofol 3Methotrexate 3Levetiracetam 3trametinib 2perampanel 2dabrafenib 2Sugammadex 2Neuroimaging 2Methylphenidate 2Magnetic Resonance Spectroscopy 2Granulocyte-Macrophage Colony-Stimulating Factor 2Gentamicins 2Fluorescein 2Anesthesia, Inhalation 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1pembrolizumab 1pegvisomant 1olutasidenib 1naxitamab 1lorlatinib 1gadoterate meglumine 1gadobenic acid 1durvalumab 1dexketoprofen trometamol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Gentamicins × CNS × Clear all
NCT02379754 2020-09-11

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

Lund University

Phase 4 Withdrawn
CNS

Neuroma, Acoustic

NCT02415257 2020-09-11

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Lund University

Phase 4 Withdrawn
CNS

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡